Page last updated: 2024-12-05

2,3,4,5,6-pentabromotoluene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6906
SCHEMBL ID95102
MeSH IDM0152129

Synonyms (37)

Synonym
AKOS015834912
DIVK1C_001232
CDS1_000192
flammex 5bt
hsdb 5253
einecs 201-774-4
benzene, pentabromomethyl-
toluene, 2,3,4,5,6-pentabromo-
2,3,4,5,6-pentabromotoluene
ccris 4854
pentabromomethylbenzene
MAYBRIDGE1_002480
87-83-2
pentabromotoluene
1,2,3,4,5-pentabromo-6-methylbenzene
HMS548I16
P0827
A842383
87007n97g5 ,
benzene, methyl-, pentabromo deriv.
benzene, 1,2,3,4,5-pentabromo-6-methyl-
unii-87007n97g5
FT-0609323
26101-97-3
2,3,4,5,6-pentabromotoluene [hsdb]
2,3,4,5,6-pentabromomethylbenzene
SCHEMBL95102
W-104004
fr-705
1,2,3,4,5-pentabromo-6-methylbenzene #
DTXSID3025833
mfcd00000060
2,3,4,5,6-pentabromotoluene, analytical standard
Q20025015
87-83-226101-97-3(replacedby87-83-2)
D92019
BS-42216

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Based on these data, it was concluded that the no observable adverse effect level for PCT was 50 ppm in the diet (3."( Pentachlorotoluene and pentabromotoluene: results of a subacute and a subchronic toxicity study in the rat.
Chu, I; McDonald, B; Secours, VE; Valli, VE; Villeneuve, DC, 1987
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.88)18.7374
1990's0 (0.00)18.2507
2000's1 (5.88)29.6817
2010's13 (76.47)24.3611
2020's2 (11.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.98 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index5.87 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]